Specializing in CNS therapies, this biopharma firm reported a notable insider sale amid a year of strong stock performance.
Beyond Meat (NASDAQ: BYND) has been an exciting stock to follow over the last year. In the span of a week, the company's share price briefly skyrocketed more than 1,000% as the stock achieved meme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results